Clearmind Medicine Inc. (CMND) income statement
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)
Close on Nov 18, 2026Market cap $484.50KP/E –Yield –
Clearmind Medicine Inc. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 4.31
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 311.9%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?